ArticleJournal of assisted reproduction and genetics2026
Does physiological sperm selection improve live birth rates in isolated teratozoospermia? A single-center retrospective cohort study.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
research questionDoes physiological intracytoplasmic sperm injection (PICSI) improve live birth outcomes compared with conventional ICSI (CICSI) in couples with isolated teratozoospermia?
designThis single-center retrospective cohort study included couples with isolated teratozoospermia, defined according to WHO (World Health Organization) 2021 criteria in the presence of normal sperm concentration and motility but abnormal sperm morphology (< 4% morphologically normal forms assessed by Kruger strict criteria), who underwent ICSI using fresh ejaculated sperm at a tertiary IVF center between 2023 and 2024. Sperm selection was performed using hyaluronan-based PICSI (n = 98) or CICSI (n = 192). Women with normal/good ovarian reserve were included in the study, whereas women with low ovarian reserve or expected poor ovarian response, as defined by the POSEIDON (Patient-Oriented Strategies Encompassing Individualized Oocyte Number) criteria, were excluded. Cycles using all forms of surgical sperm retrieval and those involving partial or complete globozoospermia sperm morphology were excluded. Preimplantation genetic testing for aneuploidy (PGT-A) was not performed in the study cohort. All embryo transfers were performed as frozen Day-5 blastocyst transfers. The primary outcome was live birth. Multivariable logistic regression was used to identify independent predictors of live birth.
resultsBaseline female and male characteristics, stimulation parameters, and semen variables were comparable between groups. The CICSI group had significantly more retrieved oocytes, MII oocytes, and total blastocysts; however, the number of ≥ 3BB blastocysts did not differ. Univariate analysis showed no significant differences in biochemical pregnancy, clinical pregnancy, miscarriage, or live birth rates between groups. Live birth rates per embryo transfer were comparable between the PICSI and the CICSI groups (56.6% vs 56.5%, respectively; p = 0.987). Despite these comparable unadjusted live birth rates, multivariable logistic regression demonstrated that PICSI was independently associated with a higher likelihood of live birth (adjusted OR 2.736; 95% CI 1.147-6.531; p = 0.023), whereas no other variable was independently predictive. Singleton birth weight was significantly higher in the PICSI group (3321 ± 475 g versus 3132 ± 572 g; p = 0.036).
conclusionsPICSI was independently associated with improved live birth outcomes in couples with isolated teratozoospermia, suggesting that sperm functional quality plays a clinically relevant role beyond conventional morphological assessment. These findings support the potential value of PICSI as a targeted sperm selection strategy in this population, although prospective validation is warranted.
Indexed as
Identifiers
42469519What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.